14-day Premium Trial Subscription Sign Up For FreeGet Free

$14.34 (2.43%)

Volume: 943k

Closed: Jan 14, 2022

Hollow Logo Score: 1.804

FibroGen Stock Forecast

$14.34 (2.43%)

Volume: 943k

Closed: Jan 14, 2022

Score Hollow Logo 1.804

FibroGen Stock Price (Quote) NASDAQ:FGEN

$14.34 ( 2.43% ) Friday, 14th Jan 2022

Range Low Price High Price Comment
30 days $12.72 $15.72 Friday, 14th Jan 2022 FGEN stock ended at $14.34. This is 2.43% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 5.58% from a day low at $13.62 to a day high of $14.38.
90 days $10.29 $15.72
52 weeks $9.88 $57.21

Historical FibroGen prices

Date Open High Low Close Volume
2022-01-14 $13.69 $14.38 $13.62 $14.34 942 898
2022-01-13 $13.81 $14.50 $13.81 $14.00 1 028 140
2022-01-12 $14.07 $14.24 $13.75 $13.80 885 738
2022-01-11 $13.76 $14.40 $13.61 $14.11 672 614
2022-01-10 $13.45 $13.96 $13.10 $13.89 1 165 865
2022-01-07 $13.96 $14.23 $13.49 $13.53 921 124
2022-01-06 $13.73 $14.13 $13.30 $13.93 800 400
2022-01-05 $14.24 $14.79 $13.73 $13.74 630 107
2022-01-04 $14.74 $14.89 $14.00 $14.37 721 659
2022-01-03 $14.43 $14.97 $14.14 $14.82 623 249
2021-12-31 $14.10 $14.41 $14.05 $14.10 494 179
2021-12-30 $14.36 $14.96 $14.04 $14.12 776 526
2021-12-29 $14.24 $14.54 $14.15 $14.32 490 852
2021-12-28 $14.86 $15.13 $14.38 $14.42 556 979
2021-12-27 $15.22 $15.35 $14.62 $14.89 786 539
2021-12-23 $15.02 $15.72 $14.93 $15.39 1 258 131
2021-12-22 $14.68 $15.05 $14.22 $14.97 741 607
2021-12-21 $14.94 $15.13 $14.48 $14.64 637 871
2021-12-20 $14.48 $15.00 $14.03 $14.80 776 603
2021-12-17 $13.88 $15.11 $13.83 $14.77 7 632 990
2021-12-16 $14.29 $14.39 $13.67 $14.00 1 528 302
2021-12-15 $13.51 $14.28 $12.72 $14.27 1 535 445
2021-12-14 $13.45 $13.71 $13.27 $13.43 1 200 734
2021-12-13 $13.72 $14.04 $13.32 $13.89 1 668 140
2021-12-10 $14.32 $14.40 $13.76 $13.99 1 626 958
2021-12-09 $14.77 $15.04 $14.22 $14.28 1 157 301
2021-12-08 $14.60 $15.15 $14.11 $15.08 1 531 713
2021-12-07 $14.31 $14.97 $14.13 $14.54 1 351 762
2021-12-06 $13.46 $14.27 $13.10 $14.19 1 627 234
2021-12-03 $13.58 $13.90 $13.09 $13.51 2 200 548
2021-12-02 $12.70 $13.80 $12.57 $13.76 1 678 187
2021-12-01 $12.50 $13.05 $12.28 $12.65 1 614 389
2021-11-30 $11.99 $12.53 $11.75 $12.51 997 785
2021-11-29 $12.44 $12.57 $11.93 $12.02 824 340
2021-11-26 $12.56 $12.84 $12.00 $12.17 882 888
2021-11-24 $12.29 $12.93 $12.11 $12.90 760 409
2021-11-23 $11.96 $12.43 $11.52 $12.41 1 199 588
2021-11-22 $12.29 $12.65 $11.94 $11.95 1 240 344
2021-11-19 $12.20 $12.50 $12.11 $12.21 1 400 424
2021-11-18 $12.44 $12.69 $12.05 $12.25 1 170 166
2021-11-17 $12.50 $12.56 $12.07 $12.34 1 911 552
2021-11-16 $12.15 $12.60 $11.89 $12.58 878 171
2021-11-15 $12.07 $12.45 $11.96 $12.21 1 398 532
2021-11-12 $12.32 $12.40 $11.96 $12.05 443 826
2021-11-11 $12.20 $12.59 $12.04 $12.22 1 224 002
2021-11-10 $12.98 $13.17 $12.09 $12.16 1 210 509
2021-11-09 $12.11 $12.14 $11.79 $12.08 877 389
2021-11-08 $13.16 $13.23 $12.07 $12.12 890 752
2021-11-05 $12.74 $13.30 $12.74 $13.15 981 651
2021-11-04 $12.73 $13.00 $12.60 $12.89 1 248 990

About FibroGen

FibroGen FibroGen, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs. It is developing roxadustat, or FG-4592, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; FG-3019, a monoclonal antibody in Phase II clinical development ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT